GLENMARK LIFE SCIENCE LTD

Factory (Manufacturer)

Glenmark Life Sciences Ltd. is an Indian company primarily engaged in the development, manufacturing, and marketing of high-quality Active Pharmaceutical Ingredients (APIs). It operates as a leading manufacturer in the pharmaceutical industry, supplying APIs globally to regulated and semi-regulated markets.

The company's core business revolves around producing APIs for a diverse range of therapeutic areas, including oncology, cardiovascular, central nervous system disorders, pain management, and anti-infectives. Beyond its extensive portfolio of generic APIs, Glenmark Life Sciences also offers Contract Development and Manufacturing Organization (CDMO) services, partnering with global pharmaceutical companies for specialized manufacturing needs.

With its robust research and development capabilities and state-of-the-art manufacturing facilities, Glenmark Life Sciences Ltd. is recognized for its commitment to quality and innovation in the life sciences sector. It was previously a subsidiary of Glenmark Pharmaceuticals Ltd. and is headquartered in Mumbai, India.

Glenmark Life Sciences Ltd primarily manufactures and sells Active Pharmaceutical Ingredients (APIs) and offers Contract Development and Manufacturing Organization (CDMO) services.

Their product portfolio includes APIs across various therapeutic areas such as:

Cardiovascular Disease

Central Nervous System

Pain Management

Diabetes

Oncology

Anti-infectives

Gastrointestinal disorders

Anti-retroviral

Anti-fungal

Anti-histamine

Anti-inflammatory

Some key API molecules they produce are:

Telmisartan

Perindopril

Teneligliptin

Adapalene

Moxifloxacin

Rilpivirine

Favipiravir

Linezolid

Atazanavir

Sacubitril

Valsartan

Rosuvastatin

Ezetimibe

Irbesartan

Olmesartan

Candesartan

Vildagliptin

Sitagliptin

Saxagliptin

Remogliflozin

Empagliflozin

Dapagliflozin

Canagliflozin

Palbociclib

Abiraterone

Enzalutamide

Alectinib

Brigatinib

Entrectinib

Lorlatinib

They also provide CDMO services for the development and manufacturing of APIs and advanced intermediates for global pharmaceutical companies.